David M. Barrett

Also affiliated with Aadi (United States), Gilead Sciences (Australia), Kite (United States), University of York

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Dissecting the Tumor–Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach”.

Dissecting the Tumor–Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3888

N/A

0DataRank · unranked

27 citations

Andrew Azzam, Yangyang Ding, David M. Barrett, Stephan A. Grupp, Kai Tan +1 more

Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1677

N/A

0DataRank · unranked

207 citations

Changya Chen, Rajat K. Das, Peng Gao, Chia‐Hui Chen, Shovik Bandyopadhyay +9 more

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

Nature Communications(2021)10.1038/s41467-020-20785-x

N/A

0DataRank · unranked

157 citations

Sakunthala Muthugounder, Samy Jambon, Rachelle Tibbetts, Long Hung, Hamid Bassiri +5 more

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Blood(2021)10.1182/blood.2021012727

N/A

0DataRank · unranked

115 citations

Kaitlin J. Devine, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda DiNofia +11 more

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States

Frontiers in Immunology(2021)10.3389/fimmu.2021.700374

N/A

0DataRank · unranked

10 citations

Chakkapong Burudpakdee, Stephan A. Grupp, Ulf H. Beier, David M. Barrett, Hamid Bassiri +1 more

Distinct bioenergetic features of human invariant natural killer T (iNKT) cells enable retained functions in nutrient-deprived states

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.29.442021

N/A

0DataRank · unranked

0 citations

Chakkapong Burudpakdee, Stephan A. Grupp, Ulf H. Beier, David M. Barrett, Hamid Bassiri +1 more

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0822

N/A

0DataRank · unranked

67 citations

Rawan Shraim, Regina M. Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri +21 more

Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0095

N/A

0DataRank · unranked

9 citations

Chia-Hui Chen, Jessica Perazzelli, Stephan A. Grupp, David M. Barrett, Kai Tan +1 more

A phenotypic screen for compounds that reverse cAMP-mediated suppression of T cell functions

SLAS DISCOVERY(2022)10.1016/j.slasd.2022.03.008

N/A

0DataRank · unranked

1 citations

Meghan Wyatt, Haim Bar, Mark K. Haynes, Bruce S. Edwards, Larry A. Sklar +2 more

Data from Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing

(2023)10.1158/2326-6066.c.6551154

N/A

0DataRank · unranked

0 citations

Chia-Hui Chen, Jessica Perazzelli, Stephan A. Grupp, David M. Barrett, Kai Tan +1 more